Cargando…
Doxycycline-encapsulated solid lipid nanoparticles as promising tool against Brucella melitensis enclosed in macrophage: a pharmacodynamics study on J774A.1 cell line
BACKGROUND: Brucellosis is a zoonotic disease caused by Brucella species. It has been estimated that more than 500,000 new cases of Brucellosis occur annually all around the world. Relapse of the disease is one of the most important challenges. The most important reason for the relapse of brucellosi...
Autores principales: | Hosseini, Seyed Mostafa, Abbasalipourkabir, Roghayyeh, Jalilian, Farid Azizi, Asl, Sara Soleimani, Farmany, Abbas, Roshanaei, Ghodratollah, Arabestani, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448226/ https://www.ncbi.nlm.nih.gov/pubmed/30988946 http://dx.doi.org/10.1186/s13756-019-0504-8 |
Ejemplares similares
-
Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study
por: Hosseini, Seyed Mostafa, et al.
Publicado: (2019) -
Co-Delivery of Doxycycline and Hydroxychloroquine Using CdTe-Labeled Solid Lipid Nanoparticles for Treatment of Acute and Chronic Brucellosis
por: Hosseini, Seyed Mostafa, et al.
Publicado: (2022) -
Brucella melitensis-Induced Transaminitis
por: Essrani, Rajesh, et al.
Publicado: (2021) -
Antimicrobial susceptibility of Brucella melitensis in Kazakhstan
por: Shevtsov, Alexandr, et al.
Publicado: (2017) -
Testicular abscesses due to Brucella melitensis
por: Vallianou, N.G., et al.
Publicado: (2018)